The first step in the colonization of the human urinary tract by pathogenic Escherichia coli is the mannosesensitive binding of FimH, the adhesin present at the tip of type 1 pili, to the bladder epithelium. We 
Introduction
Bacterial attachment to mammalian tissue constitutes the first step in the colonization of their hosts. Escherichia coli, the aetiological agent in greater than 80% of all urinary tract infections (UTIs) (Hooton and Stamm, 1997) , mediates mannose-sensitive attachment to receptors found lining the urinary tract, an event that has been shown to be critical in bladder disease (Martinez et al., 2000) . The adhesive fibre required for these hostpathogen interactions is the type 1 pilus. Type 1 pili are 1-2-mm-long composite fibres consisting of a cylindrical rod comprising repeating immunoglobulin-like (Ig) FimA pilin subunits, and a short and stubby tip fibrillum (Brinton, 1965) . They are assembled by the chaperone/usher pathway (Soto and Hultgren, 1999) and in their mature form the Ig fold of every subunit is completed by an amino-terminal extension from a neighbouring subunit in a process termed 'donor strand exchange' (Choudhury et al., 1999; Sauer et al., 1999; Barnhart et al., 2000) . FimH is the mannose recognizing adhesin. It is a twodomain protein consisting of an amino-terminal receptor binding domain linked to a carboxy-terminal pilin domain (Jones et al., 1995; Choudhury et al., 1999) . At the tip of the FimH receptor-binding domain, distal to the pilin domain, there is a pocket capable of accommodating a mannose unit . In the crystal structure of the FimH-FimC complex (Choudhury et al., 1999) , this pocket was shown to accommodate cyclohexylbutanoyl-N-hydroxyethyl-D-glucamide (C-HEGA), an additive for the crystallization, which rather distantly resembles the physiologically relevant receptor, D-mannose. The interactions of FimH with D-mannose have yet to be characterized.
FimH is a critical factor in the ability of E. coli to colonize the bladder and persist in the urinary tract. A consequence of bacterial adherence via FimH is the activation of a cascade of innate defences that leads to the exfoliation of bladder epithelial cells and an inflammatory response (Mulvey et al., 1998) . Escherichia coli are able to evade these host responses, in part, by invading into the bladder epithelium in a process that is facilitated by Molecular Microbiology (2002) 44(4), [903] [904] [905] [906] [907] [908] [909] [910] [911] [912] [913] [914] [915] Chia-Suei Hung, 1 † Julie Bouckaert,
FimH (Martinez et al., 2000) . Mice and primates vaccinated with the FimH adhesin are protected from infection (Langermann et al., 1997) . FimH binds to D-mannose and mannotriose receptors, with the former being more highly associated with cystitis isolates (Sokurenko et al., 1995; . Attachment of uropathogenic E. coli (UPEC) to the bladder epithelium is proposed to be mediated by FimH binding to the uroplakins 1a and 1b (Wu et al., 1996) . These cellular receptors contain a single Nlinked carbohydrate of the high-mannose type, common to most glycoproteins recognized by FimH. Several other reported FimH receptors include Tamm-Horsfall protein (Pak et al., 2001) , CD48 (Baorto et al., 1997) , laminin (Kukkonen et al., 1993) , collagen (Pouttu et al., 1999) , fibronectin (Schembri et al., 2000) and abiotic surfaces (Pratt and Kolter, 1999) . Based on inhibition studies, the carbohydrate binding site of FimH has been suggested to be an extended pocket with optimal fit for a trisaccharide A. Overall structure of FimCH with the two domains of the chaperone FimC (purple and pink), the pilin domain of FimH (yellow-green) that is donor strand complemented by the chaperone (Choudhury et al., 1999) (arrow) , and the receptor binding domain (green with blue helices, secondary structure labelled as described earlier (Choudhury et al., 1999) . The receptor-binding domain of FimH is an elongated 11-stranded b-barrel comprising residues Phe1 to Thr158. The D-mannose (pink), the mannose-interacting residues (green) and the residues of the hydrophobic ridge around the pocket (white) are shown in ball-and-stick model. B. A 90°rotation towards the reader of the receptor binding domain shown in A. C. Stereo presentation of omit electron density at 4s (F o -F c ) for the a-d-mannoside bound in pocket of FimH. The interacting amino acids are shown in ball-and-stick, hydrogen bonds are highlighted in purple. D. The receptor binding domain of FimH displaying the electrostatic potential surface (Nicholls et al., 1991) , with positively charged residues shown in blue, negatively charged residues in red, and neutral and hydrophobic residues in white. The residues of the hydrophobic ridge around the mannose-binding pocket are labelled.
and with a hydrophobic region in or close to the combining site (Firon et al., 1983; 1987) . Here, we present the crystal structure of the FimCH chaperone-adhesin complex bound to the D-mannose receptor, together with a mutational analysis of the FimH residues defining the mannose-binding pocket. Bacteria expressing these mutants were analysed for the ability to mediate haemagglutination of guinea pig red blood cells, the adherence and invasion into a human bladder cell line, as well as to human bladder sections in situ. Purified mutant FimH proteins were analysed for their ability to bind D-mannose and mannotriose in vitro. Our interdisciplinary studies revealed the molecular basis for the association of UTI with the binding of FimH to mannose and provide a molecular snapshot of the critical interactions necessary for persistent bladder infections.
Results

Crystal structure of FimCH in complex with a-D-mannopyranoside
The structure of the FimCH chaperone-adhesin complex bound to D-mannopyranoside was determined to 2.8 Å resolution. The mannose is buried in a unique site at the tip of the receptor-binding domain, an elongated 11-stranded b-barrel comprising residues 1-157 (Fig. 1A) , in a deep and negatively charged pocket (Fig. 1D ). Choudhury and co-workers (Choudhury et al., 1999) found the glucamide moiety of C-HEGA bound in this same pocket, in a conformation closely resembling a pyranoside. The position, configuration and orientation of the D-mannose are unambiguously defined by the electron density (Fig. 1C) . FimH selects out the alpha configuration around the free reducing anomeric oxygen O1 of the D-mannose. All of the D-mannose hydroxyl groups other than O1 interact extensively with the receptor-binding pocket of FimH. Residues Phe1, Asn46, Asp47, Asp54, Gln133, Asn135, Asp140 and Phe142 of FimH interact with D-mannose by hydrogen bonding and hydrophobic interactions. All of the residues involved in carbohydrate binding are situated at the ends of b-strands or in the loops extending from them, with the exception of Gln133, which is located within strand 10 (Fig. 1B) . Asp54 makes co-operative hydrogen bonds with O4 and O6 of the D-mannose (Fig. 1C) . O6 further directly interacts with the backbone of Asp47, the side-chain oxygen of Asn46 and the NH 2 terminal group of the FimH polypeptide. The NH 2 -terminal group makes additional interactions with O2 and O5. O2 also interacts with the only water molecule inside the pocket (W1 in Fig. 1C ). Gln133 and Asp140 bind to O3. Asn135 makes a bifurcated hydrogen-bonding interaction with O3 and O4. Phe142 makes a hydrophobic interaction with the C2-C3 bond. Phe1 stabilizes the pocket by stacking its aromatic ring with the side-chains of Gln133 and Phe144. Interestingly, the mannose-binding pocket is surrounded by a hydrophobic ridge comprising Ile13, Tyr48, Ile52 and Phe142 (Fig. 1A-D) .
Functional analysis of mannose-binding pocket
A mutational analysis of Asn46, Asp54, Gln133, Asn135 and Asp140 of FimH was carried out to probe the importance of the size and charge of these residues in interacting with the mannose receptor (Table 1 ). In addition to these residues, we investigated the role of Ser62. Position 62 is located outside the mannose-binding pocket but has been implicated in the binding of FimH to collagen type I and type IV (Pouttu et al., 1999) when it exists as an alanine. Thus, as a control, Ser62 was changed to alanine. The effect of each mutation on mannose recognition was analysed using a number of functional assays including measuring haemagglutination (HA) titre as well as analysing adherence and invasion into bladder epithelial cells. The ability of each mutant FimH protein to be assembled into the pilus was confirmed to rule out any possible assembly defects caused by a mutation. Coexpression of each of the FimH mutants with the chaperone FimC led to stable FimCH complexes, an event that is necessary for FimH assembly into a pilus , and immunofluoresence staining demonstrated that all of the FimH mutant proteins were assembled into pili (Table 1) . To enhance our insight into structure-function, correlates of the mannose-binding pocket, one of the mutant FimCH complexes (Q133N) was crystallized (see below). All of the mutations abolished FimH function as determined by the HA (Table 1 ) and bladder adherence assays ( Fig. 2A and B) , with the exception of N46D (threefold reduction) and the S62A control. Accordingly, the N46D and S62A FimH mutants were able to facilitate inva- 2E ). Bacteria were seen binding to the luminal surfaces of the bladder sections as well as the sublayers of bladder epithelium. In agreement with the functional assays described above, N46D FimH ( Fig. 2F ), but not N46A FimH (Fig. 2G) , still retained the ability to bind human bladder tissues. Binding mediated by N46D FimH was inhibited by D-mannose to the same extent as the wild type (Fig. 2E ). Other mutants tested (D54A, Q133A, Q133K) showed no binding (Fig. 2G ). Taken together, these results demonstrate that the probed residues form a major part of the receptor-binding pocket. In addition, our data reconfirms that type 1 pili-mediated binding to human bladder tissues requires a functional mannosebinding pocket on FimH.
Mannose-and mannotriose-binding activities of FimH
Different allelic variants of FimH exist among clinical isolates of UPEC and have been shown to affect the mannose-binding properties of FimH (Sokurenko et al., 1998) . These allelic variants can be broadly divided into two functional groups: those that bind mannotriose only and those that also are capable of binding Dmannose. D-Mannose binding activity has been correlated to an increased virulence phenotype amongst UPEC (Sokurenko et al., 1997) . Therefore, we investigated the effect of each mutation on D-mannose and mannotriose binding using purified FimCH complexes in enzymelinked immunoabsorbance assay (ELISA), POROS (which is a measure of mannotriose binding) and D-mannose chromatography assays. We first examined D-mannose binding. All mutant FimHs except for N46D and the S62A control were defective in D-mannose binding when tested by ELISA (Fig. 3A) . The N46D mutant, not S62A, has a reduced binding to D-mannose as detected by ELISA. Although the mutated N46A, N46D, D140A, D140N and D140E FimH proteins bound mannose-coated beads to approximately the same extent as wild-type FimH, they were eluted by methyl-a-D-mannose in significantly greater relative amounts than the wild-type or S62A FimH (Fig. 3C ), indicating that these FimH mutants have decreased mannose binding affinity.
The binding to mannotriose was next examined and compared with both mannose binding and binding to the bladder. Wild-type FimH was able to bind mannotriose approximately 10 times better than mannose ( Fig. 3A and B). The binding of N46D FimH to mannotriose was unaffected by the mutation (Fig. 3B and D) . In contrast, the N46A mutation drastically reduced binding to mannotriose (Fig. 3D) . Although mutations at Asp140 greatly reduced (D140N) or abolished (D140A, D140E) mannose binding in the ELISA and mannose bead-binding assays ( Fig. 3A and C), these mutant FimHs retained their ability to bind mannotriose (Fig. 3B ). In fact, D140N bound mannotriose ( Fig. 3B ) with the same relative affinity as wild-type FimH bound mannose (Fig. 3A) . N46D and D140N FimH were retained in the POROS assay (Fig. 3D ) similarly to wildtype FimH, confirming their ability to bind mannotriose. The N46D mutation reduced binding to bladder epithelial cells by only threefold, whereas the N46A, D140A, D140N, and D140E mutations abolished binding ( Fig. 2A  and B) . Hence, mannose and not mannotriose, appears to be the critical receptor in the colonization of uropathogenic E. coli to the bladder. Consistent with this conclusion, Q133A, N135A and N135D FimH proteins are impaired in their ability to bind bladder epithelium ( Fig. 2A and B) and mannose ( Fig. 3A and C ), yet, their ability to bind mannotriose is in part retained (Fig. 3D) . The D54A, D54N, Q133N and Q133K FimH mutants were dramatically impaired in D-mannose binding, as revealed by the fact that they exhibited virtually no detectable binding to mannose ( Fig. 3A and C) , mannotriose ( Fig. 3B and D) or bladder epithelial cells ( Fig. 2A and B) . Thus, D-mannose binding seems to be the most specific and stringent reaction that is strictly correlated with pathogenicity in the urinary tract.
Conservation of mannose-binding pocket
All of the mutations in the receptor binding pocket reduced or abolished binding to mannose and bladder epithelial cells, suggesting that the binding pocket may be highly conserved in nature. To investigate this, we sequenced the fimH gene in over 200 uropathogenic strains of E. coli and one EHEC. The alignment results can be divided into 17 groups as shown in Fig. 4 . Overall, there was very little heterogeneity in the FimH sequences among different isolates. There were no sites that varied by more than two residues suggesting systematic variation or structural restrictions. All of the residues involved in D-mannose binding and the regions around them were invariant, giving strong evidence that the mannose-binding pocket is an invariant feature of FimH in all uropathogenic strains of E. coli. EC189, the serotype O157 enterohaemorrhagic strain, shares an identical FimH sequence as O157:H7 and O157:H7 EDL933 (GenBank accession nos BAB38702 and AAG59502 respectively). All three EHEC isolates contain a mutation in the mannose-binding pocket at position 135. In UPEC, position 135 is an asparagine, whereas in the three EHEC strains it is a lysine. Mutations in UPEC FimH at position 135 (N135A and N135D) abolished the ability of FimH to bind bladder cells.
Crystal structure of the Gln133Asn mutant
The structure of the FimCH complex containing the Q133N mutation in FimH was derived from crystals grown in the presence of methyl-a-D-mannopyranoside and refined to 3 Å resolution. The mannose was bound in the mannose-binding pocket (Fig. 5C) , consistent with the residual binding affinity that Q133N FimH had to mannose-coated beads (Fig. 3C) . Asn133 did not link to O3 of the mannose. Interestingly, the mutation not only affected the interactions originally made by Gln133, but the mannose also lost all interaction with Asn135 and Asp140 (Fig. 5C) . A shift of 0.7 Å in the protein backbone at Asp140 and the mannose sugar ring from its position in the wild type, together with changes in the side-chain conformations of Asn133, Asn135, Asn138 and Asp140 (Fig. 5A ), enables these residues to take part in a very different hydrogen bonding network (Fig. 5C ) to that which was present in the wild-type FimCH-mannose structure (Fig. 5B) (the latter being identical to in the C-HEGAbound FimCH structure; Choudhury et al., 1999) . The new hydrogen bonding network stabilized the modified binding pocket and thereby included a new water molecule, W2. W2 interacted directly with O3 of mannose. W1 was conserved and interacted both with O2 of mannose and the amide group of amino acid 133, as in the wild-type complex. The a-linked methyl group on the anomeric O1 of D-mannose pointed out of the pocket and made a hydrophobic interaction with Tyr48 (3.7 Å). It is unlikely that the methyl group a-linked to the D-mannose could be responsible for any of the structural rearrangements that we observe within the pocket of the Q133N mutant, as it is physically located outside the pocket. The hydrophobic part of the Gln133 side-chain makes close van der Waals contacts with the Phe1 aromatic ring (Fig. 5B) . The shorter Asn133 side-chain compensated for the lack of the penultimate carbon Cg of Gln133 by establishing an amino-aromatic stacking interaction: Asn133 pointed its amide nitrogen atom towards the Phe1 ring (Fig. 5C ). These results explain how mutating a single side-chain can dramatically affect the geometry of the mannosebinding pocket.
Discussion
The three-dimensional structure of the FimH adhesin bound to its mannose receptor was determined, and the binding pocket was characterized by site-directed mutagenesis and an extensive functional analysis. Our structure-function studies have revealed the molecular basis of a highly conserved host-pathogen interaction that is necessary for the establishment of persistent urinary tract infections (Mulvey et al., 1998) . The FimH pocket is perfectly designed to engage in tight interactions with a monosaccharide receptor. It establishes an unusually large interface involving multiple specific interactions with its monosaccharide receptor: the solvent-accessible surface area buried at the interface between the Dmannose and FimH is 368 Å 2 compared with 312 Å 2 for methyl-a-D-mannopyranoside bound to concanavalin A (Naismith et al., 1994) , or 716 Å 2 between the P pilus adhesin, PapGII, and its tetrasaccharide receptor (Dodson et al., 2001) . A function of the hydrophobic ridge around the pocket may be to direct the sugar into the pocket in a manner that facilitates polar interactions within the FimH pocket. The reducing anomeric O1 of the Dmannose bound to wild-type FimH in our crystal structure does not interact with any FimH residue and projects into the solvent. The FimH protein imposes the aconfiguration on the C1-O1 bond of the D-mannose so that the free O1 is in a position axial to the sugar ring. Both features confirm functional binding of the D-mannose receptor in our crystal structure. In its axial position, the free O1 can make a a-glycosidic linkage, which is a prerequisite for a terminal mannose on high-mannose or hybrid type asparagine-linked oligosaccharides. A terminal mannose residue on glycoproteins was found to be a basic requirement for binding of FimH (Sokurenko et al., 1997) . On the bladder epithelium, the uroplakins 1a and 1b each expose a single N-linked carbohydrate of the high-mannose type (Wu et al., 1996) and they are therefore presumably physiological FimH receptors.
The increase in affinity of FimH for mannotriose and mannopentaose compared with D-mannose is probably due in part to the stacking of the hydrophobic face of the saccharides onto the hydrophobic ridge around the pocket, formed by Ile13, Tyr48, Ile52 and Phe142. The methyl group on O1 of methyl-a-D-mannose in the Q133N FimCH structure is involved in such a hydrophobic stacking interaction with Tyr48. The increase in affinity for the specific binding of oligomannosides is approximally to the same extent (30 times) as for the binding of mannosides carrying aromatic substituents like p- nitrophenyl-mannopyranoside (Firon et al., 1987) . Similar increases in affinity due to the addition of either sugar rings or hydrophobic substituents is a feature also observed in plant lectins that have a hydrophobic patch next to the primary binding site, e.g. concanavalin A (Bouckaert et al., 1999) . The hydrophobic character of the FimH pocket ridge distinguishes E. coli type 1 adhesins from Salmonella sp. type 1 adhesins. The latter do not seem to have increased affinity for mannose with hydrophobic substituents or for larger mannosides (Firon et al., 1984) .
Our structure-function study led us to define the structural basis for the tropism of UPEC FimH variants for terminal a-D-mannose. From all mutations in the mannose-binding pocket of FimH, N46D is the only mutation that does not completely abolish binding to bladder epithelium. The N46D mutation reduced binding to bladder cells by about threefold (Fig. 2B) , similar to its threefold reduced affinity for mannose (Fig. 3A) . On the other hand, it retained the ability to bind mannotriose with the same relative affinity as wild-type FimH (Fig. 3B) . The retained, albeit reduced, ability of N46D FimH to bind bladder cells is probably related to the fact that Asp46 can engage, at least in part, in the same interactions stabilizing the pocket as Asn46. The D140N FimH mutant retained an ability to bind mannotriose (Fig. 3B) , similar to wild-type FimH binding of mannose (Fig. 3A) , but was unable to bind bladder tissue (Fig. 2G) . Thus, mannose but not mannotriose binding appears to be strictly correlated with the physiologically relevant function of FimH in binding bladder epithelium. The co-operative hydrogen bonding of Asp54 to O4 and O6 of the mannose, and the role of this residue in the construction of the binding pocket is predominant because mutation of Asp54 (D54A and D54N) leads to complete loss of both D-mannose and mannotriose binding. This suggests that the functional mannose-binding pocket is part of the mannotriose binding site. In conclusion, even the slightest change in the mannose-binding pocket, in an atom (Asn46 Nd2) that does not directly bind to mannose (Fig. 1C) , significantly reduces binding. These data and the invariant nature of the pocket in over 200 uropathogenic isolates emphasize the finely tuned nature of this interaction. The structure of the Q133N FimH mutant (in complex with FimC) gives a novel insight into the effect of such a single residue mutation. The mutation leads not only to the loss of multiple FimH-mannose interactions, four instead of the one normally established by the mutated residue alone, but also results in a different hydrogen bonding network and a different geometry of the pocket, which render mannose binding less favourable.
Interestingly, only EHEC possess a sequence variation within the mannose-binding pocket of FimH. Enterohaemorragic strains (EHEC) are the cause of haemolytic uraemic syndrome, which results in acute kidney failure (Noel and Boedeker, 1997) . This syndrome is thought to be the effect of the Shiga toxin, which enters the blood stream and subsequently locates to the kidney because of its receptor binding specificity (Cooling et al., 1998; Kiyokawa et al., 1998 ). An inspection of the FimH gene sequences from three different O157:H7 enterohaemorragic strains revealed that the binding pocket residue Asn135 was changed to a lysine. Based on the FimH-mannose crystal structure, a lysine at this position would be predicted to exclude mannose from the binding pocket. A dysfunctional mannose-binding pocket would render EHEC strains unable to colonize the bladder and establish an infection. Indeed, although EHEC strains possess the type 1 pilus gene cluster, there is a lack of an association of EHEC strains with urinary tract infections. This may represent a natural selection for a less virulent phenotype, as colonization of the urinary tract would lead to a direct delivery of the toxin to the kidney, causing drastic and rapid consequences to the host. However, there have been several reported cases of non-diarrhoeal haemolytic-uraemic syndrome in association with urinary tract infections (Starr et al., 1998; Miedouge et al., 2000; Hogan et al., 2001) . These patients were infected with Shiga toxin-producing, non-O157:H7 E. coli. In the absence of the sequence information for these strains, we would predict that the FimH genes in these isolates do not contain mutations in the mannose-binding pocket.
The recently determined crystal structure of the PapGII receptor binding domain in complex with its specific receptor, globotetraoside (Dodson et al., 2001) , suggests structural convergence with the FimH receptor binding domain. PapGII is the adhesin on E. coli Pap pili involved in pyelonephritis. Superposition of the two receptor binding domains (r.m.s. deviation of 1.9 Å), shows that the overall shape and size of the receptor binding domains of these adhesins are remarkably similar (Fig. 6) , despite their dissimilar sequences and folds. They both are elongated molecules, approximately 22 Å wide, but variable in length. This implies a structural constringency to which these molecules should satisfy, most probably due to the passage through the usher during pilus assembly. The location and the shape of the carbohydrate binding sites grafted onto these structural platforms differs strongly and is related to the tropism of these proteins. The deep FimH binding pocket is located at the tip, whereas PapG has a more shallow and extended binding site at the side of the molecule (Fig. 6) . FimH carries the small deep pocket with an unusually large interaction surface to allow sufficiently high affinity for a single D-mannose, which is a prerequisite for pathogenicity in UTIs. It could easily interact via its tip side, with the terminal mannose on glycoproteins in the bladder. PapGII has a fourfold larger minimal receptor, and the position of the binding site at the side of (Dodson et al., 2001) .
This study combined molecular biology and macromolecular crystallography to provide a detailed structurefunction analysis of the receptor-binding pocket of FimH. The data obtained in this study provide the foundation for the development of vaccines and therapeutic drugs that target the type 1 pilus adhesin and are effective in the treatment of UTIs. In addition, because mannose binding is known to block FimH binding to human collagens (Pouttu et al., 1999) (although the mechanism is currently unknown), a mannose mimetic that inserts into the sugar-binding pocket could also prove useful in preventing septicaemia and meningitis caused by E. coli of collagen-binding phenotype in newborns.
Experimental procedures
Plasmid constructions, bacterial strains, eukaryote cell lines and mutagenesis
Plasmid pHACW18, containing the fimH gene of the urinary tract infection (UTI) strain J96, within the EcoRI-BamHI sites of pUC18, was used as the template for the site-directed mutagenesis. Plasmid pHJ9205 contained the fimC gene driven by the inducible arabinose promoter (S. J. Hultgren and C. Hal Jones, unpublished work) and was used in combination with the pHACW18 derivatives (in pMMB66 as described below) for the expression of FimCH complexes. The plasmid pUT2002, having a fimH-deleted type 1 operon driven by the natural promoter, was described previously (Minion et al., 1989) . The isopropyl-b-D-thiogalactopyranoside (IPTG)-inducible expression vector, pMMB66 (Furste et al., 1986) , and the E. coli strains MC1061 (Wertman et al., 1986) , ORN103 (Orndorff and Falkow, 1984) , C600 (Sambrook et al., 1989) and AAEC185 (Blomfield et al., 1991) (type 1 pili null) were used in this study. Site-directed mutagenesis was performed using a two-step polymerase chain reaction (PCR) as described (Hung et al., 1999) , using pHACW18 as the template. The PCR products were cloned into EcoRI and XcmI site of pHACW18. Mutations in FimH were confirmed by sequencing. Each mutant and the wildtype FimH were subcloned as an EcoRI-BamH I full-length fimH gene into pMMB66. The original pMMB66 expression vector was used as the negative control plasmid. All bacteria used were grown in Luria-Bertani broth (LB) with appropriate antibiotics. The human bladder epithelial cell line 5637 (ATCC HTB-9) was grown in RPMI1640 supplemented with 10% fetal bovine serum (FBS) and cultured according to standard tissue culture techniques.
Haemagglutination assays
ORN103/pUT2002 complemented with FimH expression constructs were induced to express FimH and type 1 pili. Briefly, bacteria were first grown overnight in shaking incubators at 37∞C. Bacteria were diluted 10-fold and subcultured statically overnight in the presence of 1 mM IPTG. Haemagglutination assays with guinea pig erythrocytes were performed following published protocols (Hultgren et al., 1990; Slonim et al., 1992) .
Bacterial surface staining of FimH proteins
Bacterial strain AAEC185 transformed with pUT2002 was complemented with either wild-type or each of the mutant FimH expression plasmids. These bacteria were cultured in the same manner as described above for FimH and type 1 pili expression. Overnight cultures were diluted to OD 600 = 1, and 1 ml of bacteria was used to immunostain for FimH on the bacterial surface. Surface-located FimH proteins were detected with anti-FimH antiserum followed by Oregon Green-conjugated goat anti-mouse IgG (H + l) secondary antibody. Bacteria were then fixed with 2% glutaraldehyde with 1 mg ml -1 of Hoechst stain (Sigma) for 5 min at room temperature (RT). The staining of FimH on bacterial surfaces was visualized with an Olympus BX60 microscope system.
Adherence and invasion assays
AAEC185/pUT2002 transformed with FimH expression plasmids were used to assay FimH-mediated bacterial adherence and invasion into a human bladder cell line, 5637. Bacteria were cultured as described above for type 1 pili expression. Adherence and invasion assays were performed with 1 h infection (Elsinghorst, 1994; Martinez et al., 2000) . Results were obtained from at least two different infection experiments with duplicate wells in each experiment. In situ binding to human bladder tissues was performed similarly to the previously described protocol with minor modifications (Falk et al., 1993; Striker et al., 1995) . Non-diseased human bladder sections were obtained from the surgical pathology and autopsy files of the Department of Pathology at Washington University. Human bladder tissues on microscope slides were deparaffinized and incubated with 100 ml of freshly FITC-labelled bacteria for 2 h at RT in a humidified chamber. Subsequently, slides were washed extensively with phosphate-buffered saline (PBS) (0.12 M NaCl, 2.7 mM KCl, 10 mM phosphate, pH 7.4), fixed for 5 min with 2.5% glutaraldehyde in PBS and counterstained with 1 mg ml -1 of Hoechst stain for 5 min. Visualization of bound bacteria was performed on an Olympus BX60 microscope system.
FimCH purification, crystallization, data collection and refinement
Bacterial strain C600/pHJ9205 transformed with FimH expression constructs was used to produce large quantities of FimCH complexes. Induction of FimC and FimH proteins were achieved with 0.1% arabinose and 0.1 mM IPTG respectively. Periplasmic extracts were isolated and the FimCH complexes were purified as described previously (Slonim et al., 1992; Barnhart et al., 2000) . The FimCH chaperone-adhesin complex was co-crystallized with D-mannopyranoside by vapour diffusion in 4 ml hanging drops. FimCH (4.7 mg ml -1 ) (2 ml) in 20 mM MES pH 6.5 and 7 mM a-Dmannose was mixed with of 1.0 M (NH 4 ) 2 SO 4 and 100 mM Tris-HCl, pH 8.2 (2 ml), and equilibrated against the latter solution. After 1 week, the drops were streak-seeded from drops containing small crystalline FimCH. Crystallizations of FimCH Q133N (4.7 mg ml -1 ) were set up in the presence of 10 mM methyl-a-D-mannopyranoside in 0.6 M (NH 4 ) 2 SO 4 , 100 mM Tris-HCl, pH 8.2. The drops were microseeded after 4 days and the bottom solution was boosted to 0.9 M (NH 4 ) 2 SO 4 after another 2 days. Single bipyramidal crystals about 0.4 mm in each dimension were fully grown after 2 weeks. For both kind of crystals, the data-sets have been collected at beamline 19BM at Advanced Photon Source, Argonne, USA ( Table 2 ). The crystals were frozen after sequentially soaking in 5% up to a final 25% glycerol in 1.2 M (NH 4 ) 2 SO 4 and 100 mM Tris-HCl, pH 8.2. Data processing was performed with HKL2000 (Otwinowski and Minor, 1997) . The space group of both crystals is C2 with strong pseudotetragonal features. Both structures were refined in a similar manner. Rigid body refinement was performed using the FimCH structure (PDB entry code 1QUN) as the starting model. The refinement was started using a high temperature (3500 K) slow-cool stage to remove model bias. Subsequent positional and individual B-factor refinements were performed without F o /s(F o ) cut-off, using CNS (Brünger et al., 1998) . At this stage, electron densities were inspected and four out of the eight molecules in the asymmetric unit were found to have good electron density, in contrast with their four non-crystallographically related partners, which had a significant part of the pilin domain of the adhesin and the chaperon disordered. The electron density of the receptor binding domain of the adhesin of all eight of the FimCH molecules was clearly defined and showed a mannoside in the carbohydrate-binding pocket. The quality of electron density allowed the addition of the solvent exposed loop residues of the chaperone molecules Leu98-Thr99 and Pro178-Gly182 that were missing from the original model. Refinement and model building led to a final R free of 0.279 for FimC-FimH-D-mannose, and 0.280 for the FimC-Q133N FimH-methyl-a-D-mannose respectively.
Binding of FimCH complexes to mannose-coated sepharose beads
Sepharose 6B were coated with saturating amounts of D-mannose (Sigma) and resuspended as 50% (v/v) slurry in 20 mM MES, pH 6.8. FimCH complexes (20 mg) were incu- bated with 100 ml of the mannose beads for 2 h in a reaction volume of 200 ml. Unbound proteins were removed and beads were washed extensively with PBS. The beads were divided into two equal portions. To one portion, 50 ml of SDS-PAGE loading buffer was added (bound FimCH); to the other half, 50 ml was incubated for 60 min with 1% methyl-a-D-mannose (eluted FimCH). Proteins in the bound and eluted fractions were resolved on 15% SDS-PAGE gels and stained with Coomassie stain.
ELISA
For ELISA experiments, Immulon 4 plates were coated overnight at 4∞C with 0.1 mg per well of mannose-or mannotriose-BSA. FimCH samples were diluted in PBS/ 0.05% Tween-20/0.1% BSA, and 100 ml of protein samples were added into each well. Bound FimCH complexes were detected with biotin-conjugated anti-FimC monoclonal Ab followed by horseradish peroxidase-conjugated strepavidin (Tropix). The ELISA reaction was developed with 3,3¢,5,5¢-Tetramethylbenzidine (KPL) substrate for 10 min and stopped with 50 ml per well of 2 N H 2 SO 4 . Reaction plates were read on SOFTmax at 450 nm.
POROS chromatography
To evaluate the mannotriose-binding affinities of FimH mutants, a high-performance liquid chromatography (HPLC)-format assay was developed using methacrylate resins (PE Biosystems). The mannotriose [Man(a1-6)]Man)-BSA conjugate was coupled to the resin via epoxide chemistry. The column, which has a bed volume of 0.2 ml, was equilibrated with modified PBS (33.3 mM phosphate, 150 mM NaCl, pH 7.2) and run at a flow rate of 1ml min -1
. Purified FimCH complexes were diluted to 10 mg ml -1 in modified PBS with 0.5% Tween-20 (mPBST), and 50 ml was injected into the column to allow interactions with the mannotriose moieties. After a 0.5 min wash with modified PBS, bound FimCH is eluted with 0.1 M H 3 PO 4 and 0.15 M NaCl for 2 min and detected by intrinsic tryptophan fluorescence, using an excitation wavelength of 280 nm and an emission wavelength of 325 nm. Affinity measurements relative to the wild-type FimH can be determined for the bound FimCH complexes, based upon the retention time profile. Results were calculated as the average of two separate experiments, with the exception of N46A.
Accession numbers
The atomic co-ordinates and the structure factors of the refined models of the D-mannose-bound FimH-FimC complex and the methyl-a-D-mannose-bound Q133N FimH-FimC complex have been deposited in the Protein Data Bank. The accession numbers are 1KLF and 1KIU respectively.
